Ticker Details
Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
IPO Date:	February 1, 1998
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$36.65M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 3.84%
Avg Daily Range (30 D):	$0.02 | 2.67%
Avg Daily Range (90 D):	$0.03 | 3.18%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	.2M
Avg Daily Volume (90 D):	.45M

Trade Size
Avg Trade Size (Sh.):	300
Avg Trade Size (Sh.) (30 D):	265
Avg Trade Size (Sh.) (90 D):	288

Institutional Trades
Total Institutional Trades:	185
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.46M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	30.67K

News

Aug 14, 2025 @ 10:21 AM Rockwell Medical Tops Q2 EPS View Source: Jesterai

Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor

May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research

Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research

Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.15	$-.01	$-.15
Diluted EPS	$-.15	$-.01	$-.15
Revenue	$69.26M	$18.35M	$69.26M
Gross Profit	$11.7M	$3.88M	$11.7M
Net Income / Loss	$-5.31M	$-.55M	$-5.31M
Operating Income / Loss	$-4.69M	$-.4M	$-4.69M
Cost of Revenue	$57.56M	$14.47M	$57.56M
Net Cash Flow	$-4.95M	$-2.9M	$-4.95M
PE Ratio

Splits
May 13, 2022	1:11